Jefferies Group’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Jefferies Group’s Portfolio SGYP Stock Details SGYP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-1,711,837	Closed	-$195K	–	2835
2018 Q4	$195K	Buy	1,711,837 +1,531,428	+849%	+$1M	﹤0.01%	1839
2018 Q3	$307K	Buy	180,409 +179,809	+29,968%	+$322K	﹤0.01%	1862
2018 Q2	$1K	Buy	+600	New	+$1.04K	﹤0.01%	2265
2017 Q3	–	Sell	-45,000	Closed	-$200K	–	2744
2017 Q2	$200K	Buy	+45,000	New	+$186K	﹤0.01%	2041
2015 Q4	–	Sell	-12,152	Closed	-$64K	–	2697
2015 Q3	$64K	Buy	12,152 +9,415	+344%	+$72.9K	﹤0.01%	2085
2015 Q2	$23K	Buy	+2,737	New	+$13.3K	﹤0.01%	2600

Other funds holding SGYP

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Jefferies Group's SGYP Position: Q1 2019 in Review

Jefferies Group sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q1 2019, closing a stake of 1,711,837 shares — an estimated $195K sold.

Jefferies Group first reported a position in SGYP in Q2 2015 and held it in 6 quarters. The position peaked at $307K in Q3 2018. 12 funds tracked by Wall St. Rank hold SGYP as of Q1 2019.

Jefferies Group reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q1 2019 after selling out during the quarter.
Jefferies Group sold 1,711,837 Synergy Pharmaceuticals, Inc Common Stock shares in Q1 2019, an estimated $195K.
Jefferies Group first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q2 2015 and held it in 6 quarters.
Jefferies Group's Synergy Pharmaceuticals, Inc Common Stock position peaked at $307K in Q3 2018.
12 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q1 2019.

Based on Jefferies Group's 13F filing for Q1 2019, filed 15 May 2019.